400 related articles for article (PubMed ID: 15237765)
21. Comparative efficacy of levocetirizine, desloratidine and fexofenadine by histamine wheal suppression test.
Dhanya NB; Thasleem Z; Rai R; Srinivas CR
Indian J Dermatol Venereol Leprol; 2008; 74(4):361-3. PubMed ID: 18797058
[TBL] [Abstract][Full Text] [Related]
22. Activity of ebastine (10 and 20 mg) and cetirizine at 24 hours of a steady state treatment in the skin of healthy volunteers.
Frossard N; Benabdesselam O; Purohit A; Mounedji N; Pauli G
Fundam Clin Pharmacol; 2000; 14(4):409-13. PubMed ID: 11030449
[TBL] [Abstract][Full Text] [Related]
23. Comparative activity of cetirizine and mizolastine on histamine-induced skin wheal and flare responses at 24 h.
Purohit A; Mélac M; Pauli G; Frossard N
Br J Clin Pharmacol; 2002 Mar; 53(3):250-4. PubMed ID: 11874388
[TBL] [Abstract][Full Text] [Related]
24. Suppression of the histamine-induced wheal and flare response by fexofenadine HCl 60 mg twice daily, loratadine 10 mg once daily and placebo in healthy Japanese volunteers.
Boyle J; Ridout F; Meadows R; Johnsen S; Hindmarch I
Curr Med Res Opin; 2005 Sep; 21(9):1495-503. PubMed ID: 16197669
[TBL] [Abstract][Full Text] [Related]
25. Comparison of efficacy, safety, and skin test inhibition of cetirizine and astemizole.
Berkowitz RB; Dockhorn R; Lockey R; Findlay S; Howland WC; Mitchell DQ; Woehler T
Ann Allergy Asthma Immunol; 1996 Apr; 76(4):363-8. PubMed ID: 8612120
[TBL] [Abstract][Full Text] [Related]
26. Effects of acrivastine, loratadine and cetirizine on histamine-induced wheal and flare responses.
Bayramgürler D; Bilen N; Apaydýn R; Altintaş L; Sal G; Dökmeci S; Utkan T
Clin Exp Dermatol; 1999 Sep; 24(5):407-11. PubMed ID: 10564333
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the effects in the nose and skin of a single dose of desloratadine and levocetirizine over 24 hours.
Passalacqua G; Guerra L; Compalati E; Massacane P; Rogkakou A; Zanella C; Baena-Cagnani R; Canonica GW
Int Arch Allergy Immunol; 2004 Oct; 135(2):143-7. PubMed ID: 15345913
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of the histamine wheal by ebastine compared with cetirizine, fexofenadine and loratadine at steady state.
Carey W; Warrington S; Boyce M; Luria X
Drugs Exp Clin Res; 2002; 28(6):243-7. PubMed ID: 12776578
[TBL] [Abstract][Full Text] [Related]
29. Relative potency of fexofenadine HCl 180 mg, loratadine 10 mg, and placebo using a skin test model of wheal-and-flare suppression.
Kaliner MA; White MV; Economides A; Crisalida T; Hale M; Liao Y; Christian CD; Georges GC; Woodworth TH; Meeves SG
Ann Allergy Asthma Immunol; 2003 Jun; 90(6):629-34. PubMed ID: 12839321
[TBL] [Abstract][Full Text] [Related]
30. Comparative Efficacy of Fexofenadine Versus Levocetrizine Versus Desloratadine via 1% Histamine Wheal Suppression Test.
Kc S; Aryal A; Adhikary M; Karn D
Kathmandu Univ Med J (KUMJ); 2020 Jan.-Mar; 18(69):19-22. PubMed ID: 33582682
[TBL] [Abstract][Full Text] [Related]
31. Consistency of the efficacy of cetirizine and ebastine on skin reactivity.
Frossard N; Melac M; Benabdesselam O; Pauli G
Ann Allergy Asthma Immunol; 1998 Jan; 80(1):61-5. PubMed ID: 9475569
[TBL] [Abstract][Full Text] [Related]
32. Suppression of wheal and flare in histamine test by the main H1 antihistamines commercialized in Brazil.
Maciel-Guerra H; Penha MÁ; Jorge MFS; Libório RDS; Carrijo ACNDA; Parise-Fortes MR; Miot HA
An Bras Dermatol; 2018 Mar; 93(2):233-237. PubMed ID: 29723372
[TBL] [Abstract][Full Text] [Related]
33. Effects of bepotastine, cetirizine, fexofenadine, and olopatadine on histamine-induced wheal-and flare-response, sedation, and psychomotor performance.
Takahashi H; Ishida-Yamamoto A; Iizuka H
Clin Exp Dermatol; 2004 Sep; 29(5):526-32. PubMed ID: 15347340
[TBL] [Abstract][Full Text] [Related]
34. A double-blind, single-dose, crossover comparison of cetirizine, ebastine, epinastine, fexofenadine, terfenadine, and loratadine versus placebo: suppression of histamine-induced wheal and flare response for 24 h in healthy male subjects.
Grant JA; Danielson L; Rihoux JP; DeVos C
Allergy; 1999 Jul; 54(7):700-7. PubMed ID: 10442525
[TBL] [Abstract][Full Text] [Related]
35. Dermal objective pharmacodynamic profile of cetirizine and epinastine: two controlled, randomised, double-blind, crossover studies.
Leroy T; van Neste D
Int J Clin Pract; 2002 Oct; 56(8):568-73. PubMed ID: 12425364
[TBL] [Abstract][Full Text] [Related]
36. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
Bachert C
Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
[TBL] [Abstract][Full Text] [Related]
37. High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study.
Siebenhaar F; Degener F; Zuberbier T; Martus P; Maurer M
J Allergy Clin Immunol; 2009 Mar; 123(3):672-9. PubMed ID: 19201016
[TBL] [Abstract][Full Text] [Related]
38. Comparative inhibition by bilastine and cetirizine of histamine-induced wheal and flare responses in humans.
Church MK
Inflamm Res; 2011 Dec; 60(12):1107-12. PubMed ID: 21874559
[TBL] [Abstract][Full Text] [Related]
39. Central nervous system effects of H1-receptor antagonists in the elderly.
Simons FE; Fraser TG; Maher J; Pillay N; Simons KJ
Ann Allergy Asthma Immunol; 1999 Feb; 82(2):157-60. PubMed ID: 10071518
[TBL] [Abstract][Full Text] [Related]
40. H1-antihistamines for chronic spontaneous urticaria.
Sharma M; Bennett C; Cohen SN; Carter B
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD006137. PubMed ID: 25397904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]